Phenix

BIMI Announces Subsidiary Phenix Bio Inc.’s New Product Launch

Retrieved on: 
Wednesday, November 8, 2023

NEW YORK, NY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Phenix Bio Inc., a wholly owned subsidiary of BIMI International Medical Inc. (NASDAQ: BIMI), a leading global healthcare provider, announces the official launch of its "CUCA 3.0 Product Line through China Duty Free Group's (CDFG) online mini program sales platform.

Key Points: 
  • NEW YORK, NY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Phenix Bio Inc., a wholly owned subsidiary of BIMI International Medical Inc. (NASDAQ: BIMI), a leading global healthcare provider, announces the official launch of its "CUCA 3.0 Product Line through China Duty Free Group's (CDFG) online mini program sales platform.
  • This significant milestone means China Duty Free’s 26 million members can now purchase Phenix’s products directly from CDFG, solidifying the previous purchase agreement between Phenix and CDFG, which became effective on August 1, 2023.

AI Robotics Company Electric Sheep Acquires Phenix Landscape and Complete Landscaping

Retrieved on: 
Wednesday, October 11, 2023

SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Electric Sheep, who is creating the first large-scale outdoor maintenance company powered by artificial intelligence and robotics, announced today two key acquisitions of landscaping businesses - Phenix Landscape and Complete Landscaping.

Key Points: 
  • SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Electric Sheep, who is creating the first large-scale outdoor maintenance company powered by artificial intelligence and robotics, announced today two key acquisitions of landscaping businesses - Phenix Landscape and Complete Landscaping.
  • Electric Sheep is an outdoor maintenance company powered by artificial intelligence and robotics.
  • What Open AI did with language, Electric Sheep wants to do for outdoor robotics - under the aircover of a profitable business model,” adds Murty.
  • “As part of Electric Sheep our customers are going to directly benefit from its proprietary AI robots that streamline time-consuming tasks like mowing.”
    “We are excited to join the Electric Sheep team and our customers are thrilled to be working with such a forward-thinking company utilizing AI technology to improve operations and efficiency,” said Derek Schendel of Phenix Landscaping.

BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of ASEAN Exclusive Distributor

Retrieved on: 
Friday, September 22, 2023

NEW YORK, NY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider today announced its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte.

Key Points: 
  • NEW YORK, NY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider today announced its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte.
  • Ltd., a Singapore company, as its exclusive distributor responsible for the distribution of Phenix's 17 herbal supplements throughout the Association of Southeast Asian Nations (ASEAN) 10 member countries.
  • Ltd., as Phenix’s exclusive distributor for the 10 ASEAN member countries, must make annual purchases of at least $5 million in order to maintain its exclusive distributor status.
  • This partnership marks a significant milestone in BIMI and Phenix's mission to enhance healthcare accessibility across the ASEAN region.

Oracle Cloud Adds AmpereOne™ Processor and Broad Set of New Services on Ampere

Retrieved on: 
Wednesday, September 20, 2023

LAS VEGAS, Sept. 19, 2023 /PRNewswire/ -- Oracle has announced their next generation Ampere A2 Compute Instances based on the latest AmpereOne™ processor, with availability starting later this year. According to Oracle, the new instances will deliver up to 44% more price-performance compared to x86 offerings and are ideal for AI inference, databases, web services, media transcoding workloads and run-time language support, such as GO and Java.

Key Points: 
  • OCI services running on Ampere are leading the way for end customers to easily migrate their workloads to the Ampere platform.
  • "That's why we are using Ampere for everything from the Oracle Database to Fusion Apps, and now, all of our OCI services.
  • Magouyrk and James said the breadth of services and applications are now running on Ampere processors within Oracle.
  • "Oracle Fusion Cloud Applications deliver the most complete suite of applications to the most complicated industries in the world.

BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free Group

Retrieved on: 
Monday, August 7, 2023

NEW YORK, NY, Aug. 07, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a leading global provider of healthcare services and innovative medical solutions, today announced the formation of a strategic partnership between its subsidiary, Phenix Bio Inc. (“Phenix”) and China Duty Free Group (“CDFG”), one of the largest and most influential state-owned duty-free retail enterprises in China.

Key Points: 
  • NEW YORK, NY, Aug. 07, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a leading global provider of healthcare services and innovative medical solutions, today announced the formation of a strategic partnership between its subsidiary, Phenix Bio Inc. (“Phenix”) and China Duty Free Group (“CDFG”), one of the largest and most influential state-owned duty-free retail enterprises in China.
  • The partnership aims to improve the accessibility of world-class dietary supplements to China's growing population, while further expanding BIMI and Phenix’s footprint in the Asian market.
  • "We are thrilled to partner with China Duty Free Group, a company that shares our commitment to excellence and innovation in the healthcare sector," said Tiewei Song, CEO of BIMI.
  • "This partnership represents a significant opportunity for our company to leverage CDFG's extensive distribution network, while offering Chinese consumers access to our best-in-class products and services.”

Oracle Cloud Infrastructure Announces OCI Compute Instances Based on New 4th Generation AMD EPYC Processors

Retrieved on: 
Tuesday, June 13, 2023

AUSTIN, Texas, June 13, 2023 /PRNewswire/ -- To make it easier for organizations to balance price and performance in their cloud environments and reduce costs, Oracle today announced plans to make available new Oracle Cloud Infrastructure (OCI) Compute E5 instances with 4th generation AMD EPYC™ processors. Unlike other cloud providers' rigid instance options that bind organizations to paying more for unused computing resources, flexible instances from OCI allow customers to allocate cores and memory as needed.

Key Points: 
  • We're expecting to use the upcoming OCI Compute E5 instances with 4th generation AMD EPYC processors as well."
  • "Currently, we run OCI Compute flexible instances with 3rd generation AMD EPYC processors and expect to be using the next generation on OCI.
  • OCI Compute, powered by 3rd generation AMD EPYC processors, provides flexibility and elasticity for our flagship products and underlying Oracle Database.
  • We look forward to the next generation of OCI Compute instances with 4th generation AMD processors."

Mullen Announces Development of Light-Weight EV Truck Body with Phenix Truck Bodies & Van Equipment of Southern California

Retrieved on: 
Monday, June 12, 2023

BREA, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today development of a light-weight truck body for its Class 3 EV with Phenix Truck Bodies & Van Equipment (“Phenix”). Phenix will develop a unique, light-weight body configuration designed to satisfy the needs of Class 3 service body truck fleets, with the goal of offering an EV alternative to ICE vehicles. Upon upfit completion, the Class 3 vehicle will be made available to Phenix commercial fleet customers for evaluation and pilot programs.

Key Points: 
  • (NASDAQ: MULN ) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, announces today development of a light-weight truck body for its Class 3 EV with Phenix Truck Bodies & Van Equipment (“Phenix”).
  • Phenix will develop a unique, light-weight body configuration designed to satisfy the needs of Class 3 service body truck fleets, with the goal of offering an EV alternative to ICE vehicles.
  • Upon upfit completion, the Class 3 vehicle will be made available to Phenix commercial fleet customers for evaluation and pilot programs.
  • Phenix Truck Bodies & Van Equipment, based in Southern California, is one of California's largest work truck, van equipment and specialty truck body manufacturers.

BIMI International Medical Inc. Announces First Quarter 2023 Financial Results

Retrieved on: 
Monday, May 22, 2023

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended March 31, 2023.

Key Points: 
  • NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended March 31, 2023.
  • Revenues for the three months ended March 31, 2023 and 2022 were $3,197,637 and $2,714,711, respectively.
  • From December 31, 2022, to March 31, 2023, BIMI experienced a decrease in cash of approximately 26.01%, from $2,336,636 to $1,730,063.
  • "We are delighted with the initial contribution from Phenix Bio Inc., and we look forward to its continued positive impact on our revenue stream," said Mr. Tiewei Song, the CEO of BIMI International Medical Inc.

Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlights

Retrieved on: 
Thursday, May 11, 2023

BEDFORD, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the first quarter ended March 31, 2023, and highlighted recent accomplishments.

Key Points: 
  • - First Presentations of Preclinical Data with GTx-mAb Development Candidate HMI-104 for PNH, and Potential for Re-Dosing with AAVHSCs, at Upcoming ASGCT Meeting -
    BEDFORD, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the first quarter ended March 31, 2023, and highlighted recent accomplishments.
  • Research and development expenses for the quarter ended March 31, 2023 were $20.0 million, compared to $24.3 million for the quarter ended March 31, 2022.
  • General and administrative expenses for the quarter ended March 31, 2023 were $8.3 million, compared to $14.1 million for the quarter ended March 31, 2022.
  • Based on current projections, Homology expects cash resources to fund operations into the fourth quarter of 2024.

BIMI Announces Results of 2023 Special meeting of Shareholders.

Retrieved on: 
Wednesday, April 19, 2023

NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the results of the Company’s 2023 Special Meeting of Shareholders held on April 13, 2023 at the offices of the Company, 15th Floor, 725 5th Avenue, New York, NY, 10022.

Key Points: 
  • NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the results of the Company’s 2023 Special Meeting of Shareholders held on April 13, 2023 at the offices of the Company, 15th Floor, 725 5th Avenue, New York, NY, 10022.
  • In accordance with Nasdaq Marketplace Rule 5635(d), the issuance of 2,000,000 shares of common stock to Mr. Oudom in consideration for his payment of $3,000,000 pursuant to a stock purchase agreement dated as of February 27, 2023, between the Company and Mr. Oudom.
  • In accordance with Nasdaq Marketplace Rule 5635(d), the issuance of 1,330,000 shares of common stock to Mr. Oudom pursuant to an agreement dated as of February 27, 2023, in consideration for the prepayment of a $2,000,000 convertible promissory note sold by the Company to Mr. Oudom on December 6, 2022.
  • Mr. Tiewei Song, the CEO of BIMI International Medical Inc., said, "On behalf of everyone at BIMI International Medical Inc., I would like to express our gratitude to Chairman Fnu Oudom for his unwavering support of our company and its subsidiaries."